Portage Biotech Newsroom

Portage Biotech Analyst Ratings

BenzingaJan 8 13:36 ET

Analysts Offer Insights on Healthcare Companies: Harpoon Therapeutics (HARP), Portage Biotech Inc (PRTG) and Ambrx Biopharma (AMAM)

TipRanksJan 8 13:00 ET

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $6

BenzingaNov 29, 2023 15:01 ET

Portage Biotech Analyst Ratings

BenzingaNov 29, 2023 15:00 ET

Portage Biotech Inc: A Buy Rating Amid Future Catalysts and Strategic Acquisitions

TipRanksNov 29, 2023 11:35 ET

Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target

BenzingaSep 7, 2023 11:38 ET

Portage Biotech Analyst Ratings

BenzingaSep 7, 2023 11:37 ET

Cantor Fitzgerald Reiterates Overweight on Portage Biotech, Maintains $11 Price Target

BenzingaAug 31, 2023 09:23 ET

Portage Biotech Analyst Ratings

BenzingaAug 31, 2023 09:22 ET

Portage Biotech Inc (PRTG) Receives a Buy From H.C. Wainwright

TipRanksAug 2, 2023 06:25 ET

HC Wainwright & Co. Maintains Buy on Portage Biotech, Lowers Price Target to $9

BenzingaAug 2, 2023 06:23 ET

Portage Biotech Analyst Ratings

BenzingaAug 2, 2023 06:23 ET

Cantor Fitzgerald Maintains Overweight on Portage Biotech, Lowers Price Target to $11

BenzingaAug 1, 2023 09:26 ET

Portage Biotech Analyst Ratings

BenzingaAug 1, 2023 09:25 ET

HC Wainwright Adjusts Portage Biotech's Price Target to $21 From $22, Keeps Buy Rating

MT NewswiresDec 1, 2022 10:22 ET

Portage Biotech Analyst Ratings

Benzinga Analyst RatingsDec 1, 2022 06:18 ET

Oppenheimer Adjusts Portage Biotech Price Target to $18 From $26, Maintains Outperform Rating

MT NewswiresNov 30, 2022 08:56 ET

Portage Biotech Analyst Ratings

Benzinga Analyst RatingsNov 30, 2022 06:58 ET

Oppenheimer Maintains Outperform on Portage Biotech, Lowers Price Target to $18

Benzinga Real-time NewsNov 30, 2022 06:58 ET

Analysts Offer Insights on Healthcare Companies: Portage Biotech Inc (PRTG) and Virios Therapeutics (VIRI)

TipRanksSep 20, 2022 06:35 ET